W. David Hardy, MD, adjunct professor of medicine, Johns Hopkins University, discusses the importance of identifying patients with undiagnosed HIV and preventing new infections for accomplishing President Trump's plan to end the HIV epidemic in 10 years.
W. David Hardy, MD, adjunct professor of medicine, Johns Hopkins University, discusses the importance of identifying patients with undiagnosed HIV and preventing new infections for accomplishing President Trump's plan to end the HIV epidemic in 10 years.
Transcript
During the State of the Union, President Trump announced the ambitious plan for ending the HIV epidemic in 10 years. What efforts are needed for this to be accomplished?
I’m glad you asked that question about the State of the Union address, because it was the entire reason I watched the address by President Trump last week. It was monumental that a president who has not had much interest in HIV actually said something very, very important. I think to really be clear about this, it’s important to state that while he said ending the epidemic, what we really are able to do and is going to be done, hopefully in the next 10 years, is stop new transmissions, meaning that we will decrease by 90% the number of new individuals who become HIV positive, which will be a huge step in the right direction.
The 2 tools we have for doing that are identification of people who are HIV positive and rapidly getting them on treatment to bring their viral load down. And as we talked about before, when U = U, transmission doesn’t occur, so we actually get a double benefit when we treat someone. They do better, they live longer, and they can’t transmit the virus. So that’s one thing we have to do—test more people, get them on medication, and keep them in medication for the long term.
The second tool we have is pre-exposure prophylaxis, or PrEP, and in that way, we can protect people who are HIV negative but who may engage in high-risk activities that make them more susceptible to HIV. We don’t have a vaccine at this point in time, we probably won’t have a vaccine for at least 10 more years, and so PrEP is really our best way to keep people uninfected. Those 2 tools used together—treatment as prevention and PrEP—are really what we’re going to have to make sure is really scaled up and rolled out and implemented so that we can really realize that 90% reduction in 10 years.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Challenges, Adaption Needed in Conducting Research for Homeless Youth Living With HIV
April 8th 2024HIV testing, treatment, and intervention session delivery were among some areas that saw challenges in properly addressing youth experiencing homelessness during an HIV prevention trial.
Read More